Outlook Therapeutics sells 8.54M shares to GMS Ventures in registered direct offering

Outlook Therapeutics, Inc.

8,539,709 shares of common stock sold to GMS Ventures and Investments under a securities purchase agreement dated May 28, 2026.
Offering made via effective S-3 shelf registration statement (File No. 333-278340).
No per-share price or gross proceeds disclosed in the filing.
Shares issued under a registered direct offering; closing expected on or about May 29, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.